Inhibition of fibulin-3 reduces immunosuppressive signaling in glioblastoma, suggesting new treatment targets.
Figure S4. Fibulin-3 knockdown does not affect the expression of some immune checkpoints.
No takes yet. Share an insight, caveat, or question.
Kundu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: